These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15140578)

  • 41. Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS.
    Dragon-Durey MA; Blanc C; Garnier A; Hofer J; Sethi SK; Zimmerhackl LB
    Semin Thromb Hemost; 2010 Sep; 36(6):633-40. PubMed ID: 20865640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology.
    Józsi M; Manuelian T; Heinen S; Oppermann M; Zipfel PF
    Histol Histopathol; 2004 Jan; 19(1):251-8. PubMed ID: 14702193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of complement in enterohemorrhagic Escherichia coli-Induced hemolytic uremic syndrome.
    Orth-Höller D; Würzner R
    Semin Thromb Hemost; 2014 Jun; 40(4):503-7. PubMed ID: 24799304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions.
    Józsi M; Heinen S; Hartmann A; Ostrowicz CW; Hälbich S; Richter H; Kunert A; Licht C; Saunders RE; Perkins SJ; Zipfel PF; Skerka C
    J Am Soc Nephrol; 2006 Jan; 17(1):170-7. PubMed ID: 16338962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition.
    Richards A; Buddles MR; Donne RL; Kaplan BS; Kirk E; Venning MC; Tielemans CL; Goodship JA; Goodship TH
    Am J Hum Genet; 2001 Feb; 68(2):485-90. PubMed ID: 11170896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.
    Manuelian T; Hellwage J; Meri S; Caprioli J; Noris M; Heinen S; Jozsi M; Neumann HP; Remuzzi G; Zipfel PF
    J Clin Invest; 2003 Apr; 111(8):1181-90. PubMed ID: 12697737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome.
    Sartz L; Olin AI; Kristoffersson AC; Ståhl AL; Johansson ME; Westman K; Fremeaux-Bacchi V; Nilsson-Ekdahl K; Karpman D
    J Immunol; 2012 Feb; 188(4):2030-7. PubMed ID: 22250080
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A case of atypical hemolytic uremic syndrome with a transient decrease in complement factor H.
    Hahn H; Um EY; Park YS; Cheong HI
    Pediatr Nephrol; 2006 Feb; 21(2):295-8. PubMed ID: 16362720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Familial hemolytic-uremic syndrome and homozygous factor H deficiency.
    Pichette V; Quérin S; Schürch W; Brun G; Lehner-Netsch G; Delâge JM
    Am J Kidney Dis; 1994 Dec; 24(6):936-41. PubMed ID: 7985673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Familial haemolytic uraemic syndrome and an MCP mutation.
    Noris M; Brioschi S; Caprioli J; Todeschini M; Bresin E; Porrati F; Gamba S; Remuzzi G;
    Lancet; 2003 Nov; 362(9395):1542-7. PubMed ID: 14615110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.
    Kavanagh D; Richards A; Fremeaux-Bacchi V; Noris M; Goodship T; Remuzzi G; Atkinson JP
    Clin J Am Soc Nephrol; 2007 May; 2(3):591-6. PubMed ID: 17699467
    [No Abstract]   [Full Text] [Related]  

  • 52. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.
    Kavanagh D; Burgess R; Spitzer D; Richards A; Diaz-Torres ML; Goodship JA; Hourcade DE; Atkinson JP; Goodship TH
    Mol Immunol; 2007 May; 44(12):3162-7. PubMed ID: 17368771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
    Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoantibodies in haemolytic uraemic syndrome (HUS).
    Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complement dysfunction in hemolytic uremic syndrome.
    Zipfel PF; Skerka C
    Curr Opin Rheumatol; 2006 Sep; 18(5):548-55. PubMed ID: 16896298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
    Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eculizumab for atypical hemolytic uremic syndrome in pregnancy.
    Ardissino G; Wally Ossola M; Maria Baffero G; Rigotti A; Cugno M
    Obstet Gynecol; 2013 Aug; 122(2 Pt 2):487-489. PubMed ID: 23884270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic studies into inherited and sporadic hemolytic uremic syndrome.
    Warwicker P; Goodship TH; Donne RL; Pirson Y; Nicholls A; Ward RM; Turnpenny P; Goodship JA
    Kidney Int; 1998 Apr; 53(4):836-44. PubMed ID: 9551389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complement in typical hemolytic uremic syndrome.
    Orth D; Würzner R
    Semin Thromb Hemost; 2010 Sep; 36(6):620-4. PubMed ID: 20865638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of a factor H mutation with hemolytic uremic syndrome following a diarrheal illness.
    Edey MM; Mead PA; Saunders RE; Strain L; Perkins SJ; Goodship TH; Kanagasundaram NS
    Am J Kidney Dis; 2008 Mar; 51(3):487-90. PubMed ID: 18295065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.